Eli Lilly and Co (NYSE: LLY) and Boehringer Ingelheim have announced that the European Commission has approved the use of Cymbalta(R) (duloxetine) for the treatment of Generalised Anxiety Disorder (GAD). This approval -- the fourth for duloxetine in Europe -- was issued on 28 July following an initial positive opinion issued by the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use...
[read full story]
Dogged by patent expirations, regulatory setbacks and high-profile drug trial failures, 2008 has been a whirlwind year for Pfizer. Pfizer, Ranbaxy Settle Lipitor Patent Litigation In June, Pfizer entered into an agreement with...
Jeff Whitley is winning the biggest challenge of his life after saving himself from alcohol and drugs hell. So tight was the grip his disease had on him, he needed a drink before he could train. Whitley’s story is very much the...
John Terry wants Chelsea to bounce back from their Roma mauling to make sure of a place in the knockout stages of the Champions League. The Blues head to Bordeaux on Wednesday looking for a victory to erase the nightmare 3-1...